Literature DB >> 22172644

There is an increased risk of atherosclerosis in hereditary angioedema.

Mustafa Demirtürk1, Nihat Polat, Göksel Güz, Ahmet Gürdal, Ibrahim Altun, Aslı Gelincik, Bahtiyar Toz, Hüseyin Oflaz, Bahattin Çolakoğlu, Murat Dal, Suna Büyüköztürk.   

Abstract

BACKGROUND: Hereditary angioedema is associated either with a deficiency in the amount or in the function of the C1 inhibitor (C1 INH).
OBJECTIVE: In this study the endothelial function of HAE patients was investigated to evaluate the impact of hereditary C1-INH deficiency on atherosclerosis, which has not yet been established before.
METHODS: A total of 26 patients (14 female, 12 male. Mean age: 38±13) diagnosed with HAE and 30 healthy controls were enrolled in the study. Measurement of coronary flow reserve (CFR) in the left anterior descending coronary artery was performed using transthoracic doppler harmonic echocardiography at baseline and following dipyridamol infusion. The intima-media thickness (IMT) in the carotid artery was measured using an echocardiographic system equipped with 10 MHz linear transducer (Vingmed System Five).
RESULTS: The mean CFR value for the HAE patient group was significantly lower than that of the control group (p<0.001). The mean IMT was not found to be significantly different between the two groups, although it was slightly higher in the HAE patient group. No correlation was found between the CFR and the disease severity scores, nor was it shown between the CFR values and the duration of danazol treatment.
CONCLUSION: Our results indicate that there is a microvascular endothelial dysfunction in HAE patients. Although carotid intima media thickness of these patients was not significantly increased, the presence of microvascular endothelial dysfunction might be regarded as an early indicator of a premature atherosclerosis.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22172644     DOI: 10.1016/j.intimp.2011.11.013

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  6 in total

1.  Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.

Authors:  Erika Kajdácsi; Péter K Jani; Dorottya Csuka; Lilian Varga; Zoltán Prohászka; Henriette Farkas; László Cervenak
Journal:  J Clin Immunol       Date:  2016-02-12       Impact factor: 8.317

Review 2.  "Nuts and Bolts" of Laboratory Evaluation of Angioedema.

Authors:  Henriette Farkas; Nóra Veszeli; Erika Kajdácsi; László Cervenak; Lilian Varga
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

3.  Role of Endothelial G Protein-Coupled Receptor Kinase 2 in Angioedema.

Authors:  Jessica Gambardella; Daniela Sorriento; Maria Bova; Mariarosaria Rusciano; Stefania Loffredo; Xujun Wang; Angelica Petraroli; Laura Carucci; Ilaria Mormile; Marco Oliveti; Marco Bruno Morelli; Antonella Fiordelisi; Giuseppe Spadaro; Pietro Campiglia; Marina Sala; Bruno Trimarco; Guido Iaccarino; Gaetano Santulli; Michele Ciccarelli
Journal:  Hypertension       Date:  2020-09-08       Impact factor: 10.190

4.  Serum fetuin-A, tumor necrosis factor alpha and C-reactive protein concentrations in patients with hereditary angioedema with C1-inhibitor deficiency.

Authors:  Bernadett Márkus; Nóra Veszeli; György Temesszentandrási; Henriette Farkas; László Kalabay
Journal:  Orphanet J Rare Dis       Date:  2019-03-18       Impact factor: 4.123

5.  Oxidative stress markers in patients with hereditary angioedema.

Authors:  Stefano R Del Giacco; Davide Firinu; Paola Lucia Minciullo; Maria Pina Barca; Paolo Emilio Manconi; Gennaro Tartarisco; Mariateresa Cristani; Antonella Saija; Sebastiano Gangemi
Journal:  Arch Med Sci       Date:  2017-07-31       Impact factor: 3.318

6.  Impaired Endothelial Function in Hereditary Angioedema During the Symptom-Free Period.

Authors:  Davide Firinu; Pier P Bassareo; Angela M Zedda; Maria P Barca; Antonio Crisafulli; Giuseppe Mercuro; Stefano Del Giacco
Journal:  Front Physiol       Date:  2018-05-16       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.